Augmented Effects of Virtual-reality Cycling Training on Upper Limb Motor Functions by NIBS in Patients With CP

January 25, 2026 updated by: Chang Gung Memorial Hospital

Augmented Effects of Virtual-reality Cycling Training on Upper Limb Motor Functions by Noninvasive Brain Stimulation in Patients With Cerebral Palsy

Cerebral palsy (CP) is the most common childhood motor disability. Weakness, spasticity, and loss of dexterity are the major problems in patients with CP. A novel virtual-reality cycling training (VCT) program was to enhance promising muscle strength and motor function through promoting the participant compliance and motivation. Non-invasive brain stimulation (NIBS), such as repetitive transcranial magnetic stimulation (rTMS) and transcranial electric stimulation (TES) has potential to augment the training effects in motor neurorehabilitation via the modulation on neuroplasticity. Therefore, this study propose a novel intervention protocol to induce superior benefits on upper extremity (UE) motor function in patients with CP.

Study Overview

Detailed Description

This study aims to investigate the augmented effects of VCT on neuromotor control and UE motor function by NIBS in patients with CP. We hypothesize that NIBS can augment the VCT effects on neuromotor control and UE motor function in patients with CP because combined therapy integrated peripheral modification techniques (VCT) and central modulation (NIBS). These effects may further enhance the activity of daily living (ADL), participation, and health related quality of life (HRQOL). This project is executed in the following two phases: to investigate the augmented effects of VCT on neuromotor control and UE motor function in patients with CP by rTMS in phase 1 (0-1.5 years) and tCS in phase 2 (1.5-3 years).

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taoyuan
      • Taoyuan District, Taoyuan, Taiwan, 333
        • Chang Gung Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of CP according to clinical criteria
  • Age 5-20 years
  • No use of botulinum toxin in the past 4 months
  • No significant perceptual or communication disturbances
  • No other peripheral or central nervous system dysfunction
  • No active inflammatory or pathologic changes in upper limb joints during the previous 6 months
  • No active medical problems, such as pneumonia, upper gastrointestinal bleeding, or urinary tract infection
  • No active problems of epilepsy and EEG without epileptiform discharge

Exclusion Criteria:

  • Metabolic disorders, such as inborn error of metabolism, electrolyte, and endocrine disorders
  • Active infectious disease, such as meningitis and encephalitis
  • Patients with active medical problems, such as pneumonia, upper gastrointestinal bleeding, or urinary tract infection
  • Poor compliance or intolerance for the TMS therapy
  • Subjects with metallic implants or pregnancy.
  • EEG show epileptiform discharge
  • Patients with family history of epilipsy
  • Patients with symptoms that are restricted from tDCS, such as epilepsy, migraine and unstable health condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: VCT and real rTMS
In virtual cycling training and intermittent theta burst stimulation group (VCT + iTBS group), they received VCT and iTBS (80% of active motor threshold) on affected hemisphere.
Virtual cycling training is a convenient and easy approach for muscle strengthening.
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.
Experimental: VCT and sham rTMS
In virtual cycling training and sham theta burst stimulation group (VCT + iTBS group), they received VCT and sham TBS stimulation.
Virtual cycling training is a convenient and easy approach for muscle strengthening.
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.
Experimental: real rTMS
In intermittent theta burst stimulation (iTBS group), they received iTBS (80% of active motor threshold) on affected hemisphere.
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.
Sham Comparator: sham rTMS
In sham theta burst stimulation (sham TBS group), they received sham TBS stimulation.
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.
Experimental: VCT and real TES
In virtual cycling training and transcranial electric stimulation group (VCT + TES group), they received TES stimulation over motor cortex.
Virtual cycling training is a convenient and easy approach for muscle strengthening.
TES is a constant current with low intensity delivered to the skull through surface electrodes.
Experimental: VCT and sham TES
In virtual cycling training and sham transcranial electric stimulation group (VCT + sham TES group), they received VCT and sham TES stimulation.
Virtual cycling training is a convenient and easy approach for muscle strengthening.
TES is a constant current with low intensity delivered to the skull through surface electrodes.
Experimental: real TES
In transcranial electric stimulation group (TES group), they received TES stimulation over motor cortex.
TES is a constant current with low intensity delivered to the skull through surface electrodes.
Sham Comparator: sham TES
In sham transcranial electric stimulation group (sham TES group), they received sham TES stimulation.
TES is a constant current with low intensity delivered to the skull through surface electrodes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Bruininks- Oseretsky Test of Motor Proficiency II at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Bruininks- Oseretsky Test of Motor Proficiency II (BOT-2) provides an overview of fine and gross motor skills in children and school-aged adolescents.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Goal Attainment Scale at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
Goal Attainment Scale (GAS) is used to help a person with cerebral palsy and their family develop personal goals for therapy (for each item minimum value is -2 and maximum value is 2, higher scores mean a better outcome).
baseline, after 6 weeks of treatment, 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Nine-Hole test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Nine-Hole Peg Test (NHPT) is used to measure finger dexterity in patients with various neurological diagnoses.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Melbourne Assessment 2 at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Melbourne Assessment 2 (MA2) is a valid and reliable tool for evaluating quality of upper limb movement in children with a neurological impairment aged 2.5 to 15 years.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Quality of upper extremity skills test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Quality of upper extremity skills test (QUEST) is an outcome measure that evaluates movement patterns and hand function in children with cerebral palsy.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Box and block test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Box and Block Test (BBT) measures unilateral gross manual dexterity.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Functional Independence Measure at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
Functional Independence Measure for Children:Applicable to infants and adolescents. The main purpose is to understand and track children's life function performance, progress and goal achievement. There are three main areas: self-care, mobility, and cognition. The score is from 1 to 7 points, 1 is completely dependent, and 7 is completely independent.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Pediatric Motor Activity Log at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Pediatric Motor Activity Log (PMAL) is a structured interview intended to examine how often and how well a child uses his/her involved upper extremity (UE) in their natural environment outside the therapeutic setting.
baseline, after 6 weeks of treatment, 3 months
Change from baseline ABILHAND Questionnaire at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The ABILHAND questionnaire assesses bimanual ability as an interview-based test focused on the patient's perceived difficulty. The ABILHAND-KIDS questionnaire is filled in by the parent of the child by rating the child's perceived difficulty of bimanual activities.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Assessment of Preschool Children's Participation at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
Preferences for Activity of Children(APCP): For children between the ages of two and five, the questionnaire model is used to allow parents to circle the level. There are 45 questions in total, so that the case or parent can review the activities in the past 4 months and ask if the child have done this activity (1 point means yes, 0 points means no).
baseline, after 6 weeks of treatment, 3 months
Change from baseline Children Assessment of Participation and Enjoyment at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
Children Assessment of Participation and Enjoyment(CAPE): Applicable to children or adolescents between the ages of six and twenty one, through questionnaires through self-reports or interviews, a total of 55 questions, asking children about the activities involved in the past four months (1 point for yes, 0 for no).
baseline, after 6 weeks of treatment, 3 months
Change from baseline Cerebral Palsy Quality of Life at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The comparison of baseline of Cerebral Palsy Quality of Life for CP after different therapy.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Motor Evoked Potential at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The comparison of baseline of Motor Evoked Potential for CP after different therapy.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Myoton at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The comparison of baseline of Myoton for CP after different therapy.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Hand dynamometer at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The comparison of baseline of hand dynamometer for CP after different therapy.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Motion analysis at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
All participants will be instructed to perform a series of upper-extremity tasks. The tasks include reaching and grasping. An 8-camera motion analysis system (Vicon system, 3-D Oxfort Metrics Ltd, Oxford, UK) is used in conjunction with a personal computer to capture the movement of markers placed on the participant's body; analog signals were collected simultaneously. Movements were recorded at 120 Hz and digitally low-pass filtered at 5 Hz using a second-order Butterworth filter. Reference markers are placed on the distal interphalangeal joints of the thumb and index finger, the styloid process of the ulna, proximal end of the second metacarpal, and the object.
baseline, after 6 weeks of treatment, 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Chia-Ling Chen, MD, PhD, Chang Gung Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 26, 2018

Primary Completion (Actual)

December 31, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

September 22, 2019

First Submitted That Met QC Criteria

September 22, 2019

First Posted (Actual)

September 25, 2019

Study Record Updates

Last Update Posted (Actual)

January 27, 2026

Last Update Submitted That Met QC Criteria

January 25, 2026

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Virtual cycling training

Subscribe